Chemical Component Summary

Name5'-[{cis-3-[2-(5-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl}(propan-2-yl)amino]-5'-deoxyadenosine
Identifiers(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(5-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-propan-2-yl-amino]methyl]oxolane-3,4-diol
FormulaC30 H42 N8 O3
Molecular Weight562.706
TypeNON-POLYMER
Isomeric SMILESCC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)O)C4CC(C4)CCc5[nH]c6ccc(cc6n5)C(C)(C)C
InChIInChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17-,19+,22-,25-,26-,29-/m1/s1
InChIKeyLXFOLMYKSYSZQS-LURJZOHASA-N

Chemical Details

Formal Charge0
Atom Count83
Chiral Atom Count4
Bond Count88
Aromatic Bond Count20

Drug Info: DrugBank

DrugBank IDDB12920 
NamePinometostat
Groups investigational
DescriptionPinometostat has been used in trials studying the treatment of Leukemia, Acute Leukemias, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Acute Lymphocytic Leukemia, among others.
Synonyms
  • PINOMETOSTAT ANHYDROUS
  • 9H-PURIN-6-AMINE, 9-(5-DEOXY-5-((CIS-3-(2-(6-(1,1-DIMETHYLETHYL)-1H-BENZIMIDAZOL-2-YL)ETHYL)CYCLOBUTYL)(1-METHYLETHYL)AMINO)-.BETA.-D-RIBOFURANOSYL)-
  • Pinometostat
Categories
  • Antineoplastic Agents
  • Heterocyclic Compounds, Fused-Ring
CAS number1380288-87-8